Symbicort and Conjunctivitis allergic - a phase IV clinical study of FDA data

Summary:

Conjunctivitis allergic is reported as a side effect among people who take Symbicort (budesonide; formoterol fumarate dihydrate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Xolair, and have Dyspnea.

The phase IV clinical study analyzes which people have Conjunctivitis allergic when taking Symbicort. It is created by eHealthMe based on reports of 112,650 people who have side effects when taking Symbicort from the FDA, and is updated regularly.

What is Symbicort?

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 114,792 Symbicort users. Check the latest studies of Symbicort.

What is Conjunctivitis allergic?

Conjunctivitis allergic (inflammation of the conjunctiva due to allergy) is found to be associated with 286 drugs and 300 conditions by eHealthMe. Check the latest studies of Conjunctivitis allergic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

112,650 people reported to have side effects when taking Symbicort.
Among them, 76 people (0.07%) have Conjunctivitis allergic.

Could Symbicort cause Conjunctivitis allergic?

Among these 76 people:

How long have people been on Symbicort when they have Conjunctivitis allergic? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Conjunctivitis allergic when taking Symbicort? *

  • female: 87.67 %
  • male: 12.33 %

What is the age of people who have Conjunctivitis allergic when taking Symbicort? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 13.79 %
  • 30-39: 1.72 %
  • 40-49: 10.34 %
  • 50-59: 20.69 %
  • 60+: 53.45 %

What are other drugs people take besides Symbicort? *

  1. Xolair: 25 people, 32.89%
  2. Imuran: 22 people, 28.95%
  3. Singulair: 22 people, 28.95%
  4. Ventolin: 21 people, 27.63%
  5. Advair Hfa: 18 people, 23.68%
  6. Prednisone: 16 people, 21.05%
  7. Omnaris: 12 people, 15.79%
  8. Albuterol Sulfate: 9 people, 11.84%
  9. Nasonex: 7 people, 9.21%
  10. Zyrtec: 7 people, 9.21%

What are other side effects people have besides Conjunctivitis allergic? *

  1. Wheezing (a high-pitched whistling sound made while you breath): 54 people, 71.05%
  2. Dyspnea (difficult or laboured breathing): 37 people, 48.68%
  3. Malaise (a feeling of general discomfort or uneasiness): 35 people, 46.05%
  4. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 33 people, 43.42%
  5. Sinusitis (inflammation of sinus): 32 people, 42.11%
  6. Pain In Extremity: 28 people, 36.84%
  7. Forced Expiratory Volume Decreased (decreased lung expired air volume): 28 people, 36.84%
  8. Itching: 28 people, 36.84%
  9. Nasopharyngitis (inflammation of the nasopharynx): 27 people, 35.53%
  10. Pneumonia: 26 people, 34.21%

What are the existing conditions these people have? *

  1. Dyspnea (difficult or laboured breathing): 20 people, 26.32%
  2. Wheezing (a high-pitched whistling sound made while you breath): 19 people, 25.00%
  3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 19 people, 25.00%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 13 people, 17.11%
  5. Sinusitis (inflammation of sinus): 6 people, 7.89%
  6. Pain: 5 people, 6.58%
  7. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 3.95%
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 2 people, 2.63%
  9. Cardiac Failure Chronic: 2 people, 2.63%
  10. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Symbicort and have Conjunctivitis allergic?

- Check whether Conjunctivitis allergic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Symbicort:

Conjunctivitis allergic treatments and more:

How severe was Conjunctivitis allergic and when was it recovered:

Expand to all the drugs that have ingredients of budesonide; formoterol fumarate dihydrate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Symbicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis allergic:

Browse all the conditions that are associated with Conjunctivitis allergic:


How the study uses the data?

The study uses data from the FDA. It is based on budesonide; formoterol fumarate dihydrate (the active ingredients of Symbicort) and Symbicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: